ZVSA
ZyVersa Therapeutics, Inc.
$0.1749
-0.06%
No data for this timeframe.
Vol
Inst. Holders2 funds
Inst. Value$26.7K
Inst. Activity0 buys / 1 sells
SEC Reports1
Recent Activity
Mar 5, 2026
SEC
ZyVersa Therapeutics raised $1 million through a private placement of convertible promissory notes and warrants to accre
8-K — Impact 4/10
Inst.
UBS Group AG — EXIT
0 shares ($0.00)
Inst.
UBS Group AG — ADD
39,280 shares ($26.6K)
May 13, 2026
earnings_calendar
ZVSA Q1 2026 Earnings Scheduled — 2026-05-13
Analyst Ratings
2Strong Buy
5Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Mar 26, 2024 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| Mar 12, 2024 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
| Feb 29, 2024 | HC Wainwright & Co. | REITERATE | Buy → Buy |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| UBS Group AG | $26.6K | EXIT |
| BANK OF AMERICA CORP | $90.00 | — |
2 institutional holders with $26.7K total value (39,412 shares) as of 2025-Q2. Top holders: UBS, BANK. Net buying activity: 1 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q2
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | UBS Group AG | 39,280 | $26.6K | 99.7% | EXIT -100.0% |
| 2 | BANK OF AMERICA CORP /DE/ | 132 | $90.00 | 0.3% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| UBS Group AG | EXIT | 39,280 | 0 | -100.0% | $0.00 | 2025-Q3 |
| UBS Group AG | ADD | 28,327 | 39,280 | +38.7% | $26.6K | 2025-Q2 |
| UBS Group AG | DOUBLED | 4,187 | 28,327 | +576.5% | $17.8K | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 12,961 | 0 | -100.0% | $0.00 | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 12,961 | — | $13.7K | 2024-Q4 |
| UBS Group AG | DOUBLED | 433 | 4,187 | +867.0% | $4.4K | 2024-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
1 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 4.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Mar 2024): 88% buy across 8 analysts — 2 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2025-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2024-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Mar 26, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Mar 12, 2024 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Feb 29, 2024 | HC Wainwright & Co. | REITERATE | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Mar 1, 2025 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Feb 1, 2025 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Jan 1, 2025 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Dec 1, 2024 | 2 | 5 | 1 | 0 | 0 | 88% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 13, 2026
earnings_calendar
ZVSA Q1 2026 Earnings Scheduled — 2026-05-13
May 11, 2026
earnings_calendar
ZVSA Q1 2026 Earnings Scheduled — 2026-05-11
Mar 25, 2026
earnings_calendar
ZVSA Q4 2025 Earnings After Market Close — 2026-03-25